Arca
Skip to content
Tools
Tools

DNA

Nucleic acid in Bacteria that 10 drugs act on.

  • Drugs that act on it: 10
  • Approved: 9
  • In phases 1 to 3: 1
  • Sponsors: 8

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 10

Approved9

  • Metronidazole
  • Nitrofurantoin
  • Tinidazole
  • Methenamine
  • Furazolidone
  • Secnidazole
  • Chloroxine
  • Hexamethyl pararosaniline
  • Nitrofurazone

Phase 30

    Phase 21

    • MGB-BP-3

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 8 of 10 act as: DNA inhibitor; the rest name their own mechanism.
      MetronidazoleBoxed warningApprovedAmbuSmall moleculeInhibitor344
      NitrofurantoinApprovedAlembic PharmaceuticalsSmall moleculeInhibitor24
      TinidazoleBoxed warningApprovedMission PharmaSmall moleculeDisrupting agentDNA disrupting agent8
      MethenamineApprovedEMSSmall moleculeInhibitor4
      FurazolidoneApprovedTakeda Pharmaceuticals USASmall moleculeInhibitor3
      SecnidazoleApprovedEvofemSmall moleculeInhibitor1
      ChloroxineApprovedWestwood-Squibb PharmaceuticalsSmall moleculeInhibitor0
      Hexamethyl pararosanilineWithdrawnApproved—Small moleculeInhibitor0
      NitrofurazoneWithdrawnApprovedTakeda Pharmaceuticals USASmall moleculeInhibitor0
      MGB-BP-3Phase 2MGB Biopharma LimitedSmall moleculeBinding agentDNA binding agent0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 31 in all, from ClinicalTrials.gov.
      AI-Guided Bronchoscopy Using the Broncho AI NavigatorMetronidazoleNot applicableRecruitingAmbu A/SNov 18, 2026
      Correlation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT ImagesMetronidazole—RecruitingDorian Technologies S.r.l.Nov 17, 2026
      Evaluating Clinical Impact of Linear Energy Transfer Distribution in Proton Therapy for Primary Brain TumoursMetronidazoleNot applicableNot yet recruitingUniversitaire Ziekenhuizen KU LeuvenNov 17, 2026
      Video-based Project to Improve Colonoscopy Quality in Lower-Volume CliniciansMetronidazoleNot applicableNot yet recruitingIndiana UniversityNov 13, 2026
      Implementing Brain Health PRO Across Diverse Settings: A Multi-Site Implementation StudyMetronidazoleNot applicableRecruitingCentre de Recherche de l'Institut Universitaire de Geriatrie de MontrealNov 13, 2026
      Exercise Metrics and Perfusion Indices in CoRonary Microvascular Dysfunction: A Multimodal Correlative Study in ANOCA and HFpEF Patients (EMPIRE-Trial)MetronidazoleNot applicableRecruitingHeart and Diabetes Center North-Rhine WestfaliaNov 12, 2026
      Investigating the Impact of Treadmill-integrated Virtual Reality Training on Walking Outside the ClinicMetronidazoleNot applicableRecruitingShepherd Center, Atlanta GANov 10, 2026
      Safety of Vonoprazan-Amoxicillin Dual Therapy Versus Concomitant Quadruple Therapy for H. Pylori EradicationMetronidazolePhase 4RecruitingIgnacio MoratorioNov 9, 2026
      Probiotics Versus Antibiotics as an Adjuvant to Non-surgical Periodontal Treatment Among Smokers With Stage II, Grade B PeriodontitisTinidazoleNot applicableRecruitingOctober 6 UniversityNov 6, 2026
      A Study to Investigate Pivmecillinam Versus Nitrofurantoin in Female Adolescents 12 to Less Than 18 Years of Age With Uncomplicated Urinary Tract InfectionNitrofurantoinPhase 2Not yet recruitingAlembic TherapeuticsOct 13, 2026
      Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori InfectionTinidazoleNot applicableNot yet recruitingAnabio R&DSep 18, 2026
      Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori EradicationTinidazoleNot applicableNot yet recruitingUniversity of Medicine and Pharmacy at Ho Chi Minh CityAug 5, 2026
      Precision Management of Urinary Tract Symptoms in Older WomenNitrofurantoinPhase 3RecruitingMegan BradleyJul 7, 2026
      Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsNitrofurantoinEarly phase 1RecruitingThe Cleveland ClinicJun 15, 2026
      Vonoprazan High-Dose Dual VS Levofloxacin ConcomitantTinidazolePhase 4Not yet recruitingDamascus HospitalJun 3, 2026
      The Effect of Different Intra-canal Medications on Postoperative PainNitrofurantoinEarly phase 1RecruitingCairo UniversityMay 22, 2026
      Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationTinidazoleNot applicableNot yet recruitingUniversity of Health Sciences LahoreMay 8, 2026
      Prophylactic Antibiotics for Outpatient Urethral BulkingNitrofurantoinPhase 4RecruitingUniversity of MiamiMar 30, 2026
      Randomized Controlled Trial of Different Antibiotic Duration Prior to Prostate Enucleation SurgeryNitrofurantoinPhase 3Not yet recruitingOhio State UniversityOct 6, 2025
      A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract InfectionMethenamine, NitrofurantoinPhase 2RecruitingUniversity College, LondonOct 2, 2025
      Urine Alkalinization for UTI in Women: RCTNitrofurantoinNot applicableNot yet recruitingAssiut UniversityOct 2, 2025
      Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue TreatmentFurazolidonePhase 4RecruitingYongquan ShiAug 24, 2025
      "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"TinidazolePhase 2RecruitingUniversity of WashingtonJul 28, 2025
      Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA InjectionMethenaminePhase 4RecruitingWomen and Infants Hospital of Rhode IslandMay 1, 2025
      Is Methenamine Prophylaxis for Urinary Tract Infection After Midurethral Sling as Effective as Antibiotic Prophylaxis?MethenamineNot applicableActive, not recruitingAtlantic Health SystemFeb 5, 2025
      The Efficacy and Safety of Keverprazan for Helicobacter Pylori EradicationFurazolidoneEarly phase 1Not yet recruitingNanjing First Hospital, Nanjing Medical UniversityJan 16, 2025
      Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue TreatmentFurazolidonePhase 3Not yet recruitingSixth Affiliated Hospital, Sun Yat-sen UniversityJan 6, 2025
      Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD SurgeryTinidazoleNot applicableActive, not recruitingThe First Affiliated Hospital of Henan University of Science and TechnologyDec 9, 2024
      Vitamin C and Hiprex in rUTIMethenamineEarly phase 1Not yet recruitingUniversity Hospitals of North Midlands NHS TrustNov 29, 2024
      Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Radical SurgeryTinidazolePhase 3Not yet recruitingThe First Affiliated Hospital of Henan University of Science and TechnologyMay 17, 2024
      Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and SecnidazoleSecnidazolePhase 4RecruitingTulane UniversityFeb 15, 2024

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364041, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.